Visualization Technology is now part of GE Medical Systems. The deal to acquire the developer of image-guided surgery (IGS) products, announced earlier this year (SCAN 2/20/02), is the second such acquisition by GE. The first, involving Surgical Insights
Visualization Technology is now part of GE Medical Systems. The deal to acquire the developer of image-guided surgery (IGS) products, announced earlier this year (SCAN 2/20/02), is the second such acquisition by GE. The first, involving Surgical Insights of Evanston, IL, closed in February. Visualization Technology is a pioneer in electromagnetic-based IGS. Its innovative technology allows continuous navigation during surgical procedures regardless of the patient's position or the location of surgical instruments.
The new business, called GE Medical Systems Navigation and Visualization, will develop and market IGS products incorporating an open platform that works in conjunction with all manufacturers' intraoperative tools, instruments, devices, and implants. This new business combines the VTI and Surgical Insights product offerings, along with future IGS offerings as they are added to the GE Medical Systems product line. The first product offering from this new business will be the OEC FluoroTrak 9800 Plus, an integrated surgery imaging solution, which will be available this summer.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.